Benjamin R. Wheeler's most recent trade in Myriad Genetics, Inc. was a trade of 549 Common Stock done at an average price of $4.6 . Disclosure was reported to the exchange on March 22, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Myriad Genetics Inc | Benjamin R. Wheeler | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.58 per share. | 22 Mar 2026 | 549 | 298,509 (0%) | 0% | 4.6 | 2,514 | Common Stock |
| Myriad Genetics Inc | Benjamin R. Wheeler | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2026 | 206,186 | 303,810 (0%) | 0% | 0 | Common Stock | |
| Myriad Genetics Inc | Benjamin R. Wheeler | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.66 per share. | 12 Mar 2026 | 2,192 | 299,058 (0%) | 0% | 4.7 | 10,215 | Common Stock |
| Myriad Genetics Inc | Benjamin R. Wheeler | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.66 per share. | 12 Mar 2026 | 1,097 | 302,127 (0%) | 0% | 4.7 | 5,112 | Common Stock |
| Myriad Genetics Inc | Benjamin R. Wheeler | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.66 per share. | 12 Mar 2026 | 877 | 301,250 (0%) | 0% | 4.7 | 4,087 | Common Stock |
| Myriad Genetics Inc | Benjamin R. Wheeler | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.66 per share. | 12 Mar 2026 | 586 | 303,224 (0%) | 0% | 4.7 | 2,731 | Common Stock |
| Myriad Genetics Inc | Benjamin R. Wheeler | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 4,994 | 97,624 (0%) | 0% | 0 | Common Stock | |
| Myriad Genetics Inc | Benjamin R. Wheeler | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.57 per share. | 25 Dec 2025 | 21 | 92,630 (0%) | 0% | 6.6 | 138 | Common Stock |
| Myriad Genetics Inc | Benjamin R. Wheeler | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.77 per share. | 21 Sep 2025 | 2,559 | 92,651 (0%) | 0% | 7.8 | 19,883 | Common Stock |
| Myriad Genetics Inc | Benjamin R. Wheeler | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Aug 2025 | 60,000 | 95,210 (0%) | 0% | 0 | Common Stock |